bioAffinity Technologies Reports $2.4 Million Revenue for Q3 2024

Go back to bioAffinity Technologies Reports $2.4 Million Revenue for Q3 2024
(NASDAQ: BIAF) Delayed: 0.42 +0.01 (2.44%)
Previous Close $0.41    52 Week High
Open $0.39    52 Week Low
Day High $0.44    P/E N/A 
Day Low $0.37    EPS
Volume 2,487,615       

(NASDAQ: BIAFW) Delayed: 0.10 -0.02 (16.67%)
Previous Close $0.12    52 Week High
Open $0.08    52 Week Low
Day High $0.10    P/E N/A 
Day Low $0.08    EPS
Volume 1,000